Managing the Risk of Payment Default in Pharmaceutical Manufacturing Companies

Keywords

accounts receivable
bank guarantee
factoring
insurance
credit control
pharmaceutical market
pharmaceutical enterprise
current assets
solvency
accounts receivable management

How to Cite

Ибрагимова, Е. Ю. (2025). Managing the Risk of Payment Default in Pharmaceutical Manufacturing Companies. Risk Managmenent, 1. https://riskmanagementjournal.ru/index.php/rmj/article/view/491

Abstract

The article examines the key aspects of managing the risk of deferred payment in manufacturers of pharmaceutical products. The relevance of the topic is due to the high volatility of the pharmaceutical market and the specific features of the pharmaceutical industry, where timely payments are critical to maintaining financial stability. The article analyzes the main causes of overdue accounts receivable. It also considers strategies for minimizing the risk of non-payment by counterparties, such as the use of factoring, bank guarantees and trade credit insurance, as well as the development of a flexible credit policy. The results of the study emphasize the importance of an integrated approach to risk management, which includes both preventive measures and effective mechanisms for responding to emerging problems. The article is aimed at the heads of financial services, analysts and specialists in the field of accounts receivable management, as well as for researchers studying financial management in the pharmaceutical industry.